Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.

Back

ESC Premium Access

Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.

Session: Poster session 5 - Comorbidities and mortalities

Topic: Atrial fibrillation (AF)

Speaker: Doctor T. Liu (Tianjin, CN)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Tong Liu

2nd Hospital of Tianjin Medical University, Tianjin (China)

1 follower

10 more presentations in this session

Mortality and atrial fibrillation in the FIACA study: evidence of a differential effect according to the diagnosis of hospital admission.

Speaker: Doctor D. Fernandez-Berges (Villanueva de la Serena, ES)

Access

Abstract

Slides

Multimorbidity and comorbidity in atrial fibrillation and effects on survival: findings from UK biobank cohort

Speaker: Professor D. Connelly (Glasgow, GB)

Access

Abstract

Patients with cancer and atrial fibrillation treated with NOACs: data from a prospective cohort

Speaker: Doctor M. Vedovati (Perugia, IT)

Access

Abstract

Slides

Comorbid malignancy as an independent predictor of in-hospital mortality in patients with atrial fibrillation.

Speaker: Doctor K. Voudris (Chicago, US)

Access

Abstract

Slides

Increased bleeding risk in cancer patients with atrial fibrillation. Can we identify risk predictors?

Speaker: Doctor A. Pardo Sanz (Madrid, ES)

Access

Abstract

Slides

Access the full session

Poster session 5 - Comorbidities and mortalities

Speakers: Doctor T. Liu, Doctor D. Fernandez-Berges, Professor D. Connelly, Doctor M. Vedovati, Doctor K. Voudris...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources